webinar register page

Webinar banner
COA Measurement Strategy in Modern Oncology Trials
Signant has decades of experience across nearly 1,000 oncology trials as well as the clinical science expertise to help sponsors develop effective clinical outcome assessment (COA) measurement strategies.

Join us on Wednesday, October 26, as our in-house oncology and eCOA specialists walk attendees through:

▷ An overview of the FDA draft guidance on patient-reported outcomes in oncology trials
▷ PROM selection and adaptation
▷ The promise of item banks
▷ Key considerations for eCOA implementation

Oct 26, 2022 11:00 AM in Eastern Time (US and Canada)

Webinar logo
* Required information


Bill Byrom, PhD
Principal, eCOA Science @Signant Health
Dr. Byrom has worked in the pharmaceutical industry for 30 years. He has authored over 70 publications and two industry textbooks on electronic patient-reported outcomes (ePRO). His recent scientific work includes the use of wearable technology and bring-your-own-device (BYOD) eCOA in clinical trials
Todd Everhart, MD
Clinical Vice President Internal Medicine @Signant Health
Dr. Everhart is an innovator, educator, and leader in the pharmaceutical and biotechnology industries with over 25 years of experience in the practice of medicine and over 14 years of experience in clinical research. Board-certified in Internal Medicine and a Fellow of the American College of Physicians, he is one of Signant Health’s experts in decentralized trials, rater training, blinded data analytics, and placebo response mitigation.